✦ LIBER ✦

Efficacy, safety and tolerability of rivastigmine patch 13.3 mg/24 h (15 cm2) versus 4.6 mg/24 h (5 cm2) in patients with severe Alzheimer's disease: Results of the ACTivities of daily living and cognitION (ACTION) study

✍ Scribed by Farlow, Martin; Meng, Xiangyi; Rensch, Scott; Somogyi, Monique

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety and tolerability of riv

✍ Farlow, Martin; Meng, Xiangyi; Somogyi, Monique 📂 Article 📅 2013 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 61 KB

Long-term safety and efficacy of 13.3mg/

✍ Farlow, M.; Grossberg, G.; Sadowsky, C.; Meng, X.; Somgyi, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

A 24-week, open-label extension to the A

✍ Farlow, Martin; Grossberg, George; Sadowsky, Carl; Meng, Xiangyi; Somogyi, Moniq 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy, safety and tolerability of a h

✍ Grossberg, George; Farlow, Martin; Meng, Xiangyi; Somogyi, Monique 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Effect of body mass index on the efficac

✍ Sadowsky, Carl; Somogyi, Monique; Frolich, Lutz; Meng, Xiangyi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Incidence and predictors of response to

✍ Molinuevo, Jose Luis; Grossberg, George; Frölich, Lutz; Galvin, James; Krahnke, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 150 KB